Search Results 831-840 of 18208 for Immunode

1. MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer - Mayo Clinic

   Human immunodeficiency virus (HIV)-positive test result or history of other immunodeficiency. History of organ transplantation. History of chronic hepatitis ...

2. A Study Evaluating the Addition of Venetoclax (ABT-199) to Patients with Multiple Myeloma who are Receiving Bortezomib and Dexamethasone as Standard Therapy - Mayo Clinic

   Amyloidosis; POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes); Known Human Immunodeficiency Viral (HIV) ...

3. Neonatally-Derived Tissues for Biotherapeutic Manufacturing - Mayo Clinic

   About this study. The purpose of this study is to create a shared Mayo Clinic resource for biotherapies derived from various perinatal tissues (umbilical ...

4. Novel Study Interventions and Combinations in Participants with Colorectal Cancer - Mayo Clinic

   Known history of immunodeficiency, or other acquired, congenital immunodeficiency disorders, or history of organ transplantation and allogeneic bone marrow ...

5. Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

   Subject is known to have human immunodeficiency virus infection; Subject has active hepatitis B or C, or other active hepatic disorder. Participating Mayo ...

6. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Human immunodeficiency virus (HIV), hepatitis B, or hepatitis C viral screening test showing evidence of active or chronic viral infection at Screening or a ...

7. Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors - Mayo Clinic

   Known prior history of human immunodeficiency virus (HIV); Administration of live vaccines =< 14 days prior to registration; note: patients may not receive ...

8. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

   Immunocompromised patients and patients known to be human immunodeficiency virus (HIV) positive; Hypersensitivity to pegfilgrastim or Escherichia (E.) coli ...

9. A Study of Using Mesenchymal Stem Cells Developed from the Patients Own Fat Tissue for Reducing Hemodialysis Arteriovenous Fistula Failure - Mayo Clinic

   Immunodeficiency including AIDS / HIV or Active autoimmune disease. Documented hypercoagulable state or history of 2 or more DVTs or other spontaneous ...

10. Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris - Mayo Clinic

    Participation eligibility · Vulnerable study population · Pregnant or nursing women · Women planning a pregnancy within the study period · Human immunodeficiency ...